Loading...

3SBio Inc.

TRSBF•PNK
Healthcare
Biotechnology
$2.83
$0.00(0.00%)
U.S. Market opens in 2h 8m

3SBio Inc. (TRSBF) Stock Overview

Explore 3SBio Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap6.7B
P/E Ratio5.60
EPS (TTM)$0.14
ROE0.38%
Fundamental Analysis

AI Price Forecasts

1 Month$2.72
3 Months$4.38
1 Year Target$6.09

TRSBF Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of 3SBio Inc. (TRSBF) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 45.49, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $6.09.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 5.60 and a market capitalization of 6.7B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
N/A
5-Day Change
-0.18%
1-Month Change
8.24%
3-Month Change
-14.13%
6-Month Change
-21.09%
Year-to-Date (YTD) Change
-20.65%
1-Year Change
241.22%
3-Year Change
253.13%
5-Year Change
210.44%
All-Time (Max) Change
16.74%

Contact Information

https://www.3sbio.com
86 24 2538 6000
No. 3 A1, Road 10, Shenyang, NaN, 110027

Company Facts

5,577 Employees
IPO DateJun 26, 2018
CountryCN
Actively Trading

Frequently Asked Questions